A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel Group, Phase 2, Two-Part Adaptive Study to Evaluate the Safety and Efficacy of VPI-2690B Injection in Patients With Nephropathy Due to Diabetes
The purpose of this study is to determine whether VPI-2690B Injection is effective in the treatment of diabetic nephropathy.
100 项与 VPI-2690B 相关的专利(医药)